Skip to content

Homepage

Author: Annexon Biosciences

Posted Date:

June 16, 2026

Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)

Annexon Biosciences

June 16, 2026
Annexon to Participate in Upcoming June Investor Conferences

Annexon Biosciences

May 27, 2026
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)

Annexon Biosciences

May 18, 2026
Annexon Reports First Quarter 2026 Financial Results, Portfolio Progress and Key Anticipated Milestones

Annexon Biosciences

May 7, 2026
Annexon to Present at the Bank of America Securities Health Care Conference 2026

Annexon Biosciences

May 6, 2026
Annexon to Present at the 25th Annual Needham Virtual Healthcare Conference

Annexon Biosciences

April 8, 2026
Annexon Reports Fourth Quarter and Year-End 2025 Financial Results, Portfolio Progress and Key Anticipated Milestones

Annexon Biosciences

March 31, 2026
Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)

Annexon Biosciences

March 16, 2026
Annexon Biosciences to Present at the TD Cowen 46th Annual Health Care Conference

Annexon Biosciences

February 24, 2026
Annexon to Host In-Person and Virtual KOL Event to Discuss Vonaprument for the Treatment of Geographic Atrophy

Annexon Biosciences

February 17, 2026